According to Eric Fry, only one device can save us from the looming threat posed by Artificial Intelligence.
That device is Elon Musk's Neuralink, which despite being privately owned, we can still profit from using a clever backdoor strategy.
The Teaser
What Neuralink is and what it does is the stuff of science fiction, but as crazy as it sounds, rest assured it's the real deal.
Eric Fry is a seasoned investment pro, with over two decades of money management and publishing experience behind him. We have previously exposed many of Eric's stock picks and his fascination with AI.
So, what exactly is Neuralink?
To put it simply, Elon Musk wants to merge human brains with artificial intelligence (AI).
Now that you see we weren't joking about the sci-fi part, how is this merger between man and machine going down?
The Third And Final Phase of the Computing Revolution
The first two phases were all about the advent of the personal computer and the Internet. Two significant historical events.
According to Eric, the third phase will be dominated by AI, but not just any kind of AI.
A brain/machine interface is what Elon has helped build to create a direct line of communication between the human brain and computers for the first time ever.
According to the man himself, merging with AI in this fashion is the only option we humanoids have to not get left behind.
It all started with an experiment called PRIME, which stands for “Precise Robotically Implanted Brain-Computer Interface.”
Like the personal computer and the internet before it, PRIME leverages a technology partially developed by the Defense Advanced Research Projects Agency (DARPA). Using this technology, Musk and his Neuralink team built a unique robotic brain surgeon that can do something not even the best neurosurgeons of today can do.
It can precisely implant a device in the region of the brain that controls our intention to move.
The device itself looks like this:
This past January it was implanted in the first human patient, meaning we're just at the start of a miraculous growth story.
The Pitch
Neuralink, at this point, is still a private company. However, one well-known tech stock can give us exposure to its growth, and Eric has put all the details on it in a special report called How to Profit From Elon Musk’s Neuralink.
This company is scheduled to make an announcement on July 23rd that could send shares skyrocketing higher, so we will want to have a no-risk trial subscription to Eric's monthly investment newsletter, Fry’s Investment Report by then.
A subscription costs $49 and it comes with a 90-day money-back guarantee, at least one new investment recommendation per month, full access to an online archives section to see how past recommendations have panned out, and a few bonus reports.
A New Reality
Neuralink's first human patient was a 29-year-old with quadriplegia named Noland Arbaugh.
This means that Noland had been paralyzed from the neck down following a car accident in 2016, so the goal of participating in the trial called PRIME Study was to hopefully give him the ability to control a computer cursor or keyboard using his thoughts alone.
Following some minor complications, Noland can now direct a computer mouse with his brain.
From this standpoint, the trial has been a success and it's just the beginning.
Telepathy
Neuralink's first planned product is aptly called Telepathy and it's aimed at those who have lost the use of their limbs.
Eventually, restoring lost vision, speech, and hearing are all possibilities.
It all sounds a way off, as Neuralink's technology still needs regulatory approval before it can hit the consumer market. But it is bringing what once sounded downright crazy, closer to reality.
Even Google's Chief Engineer Ray Kurzweil has said singularity – the combination of man with machine, is “the next step of our evolution.”
I'm as skeptical as anyone on if this should happen, rather than when it will happen. However, Elon's proposed technology does have some clear benefits as we saw in Noland's case, which brings us to the investment opportunity.
Eric has found an investment that will give us direct exposure to Neuralink, which is still privately owned by Elon.
Many people don't know about this investment's Neuralink connection, but some of the savviest investors, including Warren Buffett already have a stake in it. Let's find out what it is.
How to Profit from Elon Musk's Neuralink…Revealed
Clues about this stock aren't just scarce, they are practically non-existent. All we get is that:
- Warren Buffett invested in this stock through a little-known asset management subsidiary.
- Hedge fund manager Bill Ackman also owns a couple of billion dollars worth of this stock.
Eric has done a good job making it extra tough for us, just as like it, but we still managed to get to the bottom of things.
The pick is Alphabet Inc. (Nasdaq: GOOG), as Google Ventures is among Neuralink's backers. Also, the few clues we got match up:
- Berkshire Hathaway owns a subsidiary called New England Asset Management (NEAM). This investment firm has owned GOOG stock since the fourth quarter of 2022.
- Bill Ackman's Pershing Square Capital Management owns around $2 billion of Alphabet stock.
Second Chance at Life-Changing Gains?
Eric argues that if we missed out on profiting from personal computers and smartphones, now is our second chance to cash in on similar type of gains.
Is he right?
First, Alphabet Inc. is GV's, formerly Google Ventures, sole limited partner and although the firm operates independently, it acts as Alphabet's venture capital arm.
In this regard, we would get some exposure to Neuralink by owning Alphabet stock.
However, since GV doesn't break down its holdings and it manages over $10 billion spread across nearly 400 investments, there's no way to know how large its Neuralink stake is.
Leaving this aside for a moment, Neuralink itself is still a few years away from coming to market, as it is only in the first phase of approved clinical trials.
Finally, even though investments in Tesla and SpaceX have worked out well over the long term. There's no guarantee that Neuralink won't go the way of the Hyperloop.
All we have to go on at the moment is a grand total of one human patient in the first phase of clinical trials.
Will having a brain chip implant be 1,000x bigger than the smartphone as Eric envisions? I have some serious doubts.
Quick Recap & Conclusion
- Eric Fry says only one device can save us from the looming threat posed by Artificial Intelligence and we can profit from it using a clever backdoor strategy.
- This device is Elon Musk's Neuralink, which recently underwent its first successful human trial this past January.
- At this time, Neuralink is still a private company. But one well-known tech stock can give us exposure to its growth and Eric has put all the details on it in a special report called How to Profit From Elon Musk’s Neuralink. The report is ours with a no-risk trial subscription to Eric's monthly investment newsletter, Fry’s Investment Report, which costs $49 for a limited time.
- All we got from Eric were a couple of flimsy clues, but that was enough to reveal his pick for free as Alphabet Inc. (Nasdaq: GOOG), which in-directly owns an equity stake in Neuralink via its GV, venture capital subsidiary.
- Neuralink is still a very early-stage venture with no guarantee that it will even come to market with its proposed product, let alone be successful. But it is a compelling story to follow.
Will man ever merge with machine? Let us know what you think about such a future in the comments.
For this to be close to a life-changing gains, the stock would have to increase by at least 5 times its current price. This means GOOG would have to soar to $8,700. Does anyone really think that GOOG will exceed $8,700 per share? To do that Neuralink would have to have amazing results and be able to produce thousands of the devices; let alone not launch its own IPO. I don’t see them staying in GOOG, but this launching its own IPO. Just don’t see this having life-changing gains if it stays inside GOOG.